About Us
R&D Overview
Collaborations
News & Events
Contact Us
Investors
Working For Chroma
There are currently no scheduled events.
Tosedostat Opal Study In Acute Myeloid Leukaemia Published In Lancet Oncology
Chroma Therapeutics Advances Novel Targeted Agent Towards Clinical Development; Receives Milestone Payment And Extends Collaboration With GSK